{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:39:14Z","timestamp":1790757554376,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.diagmicrobio.2017.10.018","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T02:30:31Z","timestamp":1510021831000},"page":"123-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with hematological disorders: A retrospective analysis"],"prefix":"10.1016","volume":"90","author":[{"given":"Hiroyuki","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8959-6271","authenticated-orcid":false,"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunai","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouhei","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-4284","authenticated-orcid":false,"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0005","first-page":"313","article-title":"Sodium chloride treatment of amphotericin B nephrotoxicity. Standard of care?","volume":"162","author":"Anderson","year":"1995","journal-title":"West J Med"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0015","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/archinte.1988.00380110049010","article-title":"Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation","volume":"148","author":"Branch","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0020","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.diagmicrobio.2017.10.018_bb0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1179\/joc.2005.17.1.82","article-title":"Penetration of amphotericin B in human lung tissue after single liposomal amphotericin B (AmBisome) infusion","volume":"17","author":"Demartini","year":"2005","journal-title":"J Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000452702","article-title":"Intravenous fluids and acute kidney injury","volume":"43","author":"Ding","year":"2017","journal-title":"Blood Purif"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0040","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.4269\/ajtmh.2006.75.1108","article-title":"Oral rehydration solution to prevent nephrotoxicity of amphotericin B","volume":"75","author":"Echevarria","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0050","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9343(89)80612-6","article-title":"Risk factors for amphotericin B-associated nephrotoxicity","volume":"87","author":"Fisher","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0055","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/653606","article-title":"Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety","volume":"51","author":"Hamill","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/0250-474X.89757","article-title":"Formulation and evaluation of long circulating liposomal amphotericin B: a Scinti-kinetic study using Tc in BALB\/C mice","volume":"73","author":"Jadhav","year":"2011","journal-title":"Indian J Pharm Sci"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0070","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0075","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1517\/14740338.2012.721775","article-title":"Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity?","volume":"11","author":"Karimzadeh","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/bjs.9651","article-title":"Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation","volume":"102","author":"Krajewski","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","article-title":"Amphotericin B: side effects and toxicity","volume":"26","author":"Laniado-Laborin","year":"2009","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0090","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ki.1991.214","article-title":"Effect of salt supplementation on amphotericin B nephrotoxicity","volume":"40","author":"Llanos","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/341662","article-title":"Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study","volume":"186","author":"Mayer","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0100","first-page":"9","article-title":"Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients","volume":"5","author":"Miceli","year":"2012","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0105","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jac\/dkm220","article-title":"Proteinuria lowers the risk of amphotericin B-associated hypokalaemia","volume":"60","author":"Mohan","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s13181-010-0120-8","article-title":"An evaluation of hepatotoxicity and nephrotoxicity of liposomal amphotericin B (L-AMB)","volume":"7","author":"Patel","year":"2011","journal-title":"J Med Toxicol"},{"issue":"Suppl. 5","key":"10.1016\/j.diagmicrobio.2017.10.018_bb0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1469-0691.2009.02987.x","article-title":"Lipid formulations of amphotericin B as first-line treatment of zygomycosis","volume":"15","author":"Petrikkos","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0120","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1128\/AAC.00525-15","article-title":"Incidence, predictors, and impact on hospital mortality of amphotericin B nephrotoxicity defined using newer acute kidney injury diagnostic criteria","volume":"59","author":"Rocha","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0125","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1128\/AAC.35.12.2509","article-title":"Mechanisms of amphotericin B-induced decrease in glomerular filtration rate in rats","volume":"35","author":"Sabra","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12882-017-0460-6","article-title":"Fluid overload is an independent risk factor for acute kidney injury in critically ill patients: results of a cohort study","volume":"18","author":"Salahuddin","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0135","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1681\/ASN.V62154","article-title":"Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties","volume":"6","author":"Sawaya","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0140","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1172\/JCI106270","article-title":"Defect in urinary acidification induced in vitro by amphotericin B","volume":"49","author":"Steinmetz","year":"1970","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jiac.2016.01.009","article-title":"Safety and efficacy of treatment with liposomal amphotericin B in elderly patients at least 65 years old with hematological diseases","volume":"22","author":"Ueda","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0150","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/jac\/dkl141","article-title":"Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion","volume":"57","author":"Vogelsinger","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0155","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases mycoses study group","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0160","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1086\/514672","article-title":"Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia","volume":"27","author":"White","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2017.10.018_bb0165","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/317451","article-title":"A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph\/ABLC collaborative study group","volume":"31","author":"Wingard","year":"2000","journal-title":"Clin Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889317303425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889317303425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T16:09:45Z","timestamp":1659802185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889317303425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0732889317303425"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2017.10.018","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with hematological disorders: A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2017.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}